These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37200250)

  • 1. Long lasting anti-IgG chikungunya seropositivity in the Mayotte population will not be enough to prevent future outbreaks: A seroprevalence study, 2019.
    Ortu G; Grard G; Parenton F; Ruello M; Paty MC; Durand GA; Hassani Y; De Valk H; Noël H;
    PLoS One; 2023; 18(5):e0285879. PubMed ID: 37200250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey.
    Sissoko D; Moendandze A; Malvy D; Giry C; Ezzedine K; Solet JL; Pierre V
    PLoS One; 2008 Aug; 3(8):e3066. PubMed ID: 18725980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological Evidence of Contrasted Exposure to Arboviral Infections between Islands of the Union of Comoros (Indian Ocean).
    Dellagi K; Salez N; Maquart M; Larrieu S; Yssouf A; Silaï R; Leparc-Goffart I; Tortosa P; de Lamballerie X
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0004840. PubMed ID: 27977670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of Chikungunya Virus in an Urban Slum, Brazil.
    Anjos RO; Mugabe VA; Moreira PSS; Carvalho CX; Portilho MM; Khouri R; Sacramento GA; Nery NRR; Reis MG; Kitron UD; Ko AI; Costa F; Ribeiro GS
    Emerg Infect Dis; 2020 Jul; 26(7):1364-1373. PubMed ID: 32568045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.
    Hennessey MJ; Ellis EM; Delorey MJ; Panella AJ; Kosoy OI; Kirking HL; Appiah GD; Qin J; Basile AJ; Feldstein LR; Biggerstaff BJ; Lanciotti RS; Fischer M; Staples JE
    Am J Trop Med Hyg; 2018 Nov; 99(5):1321-1326. PubMed ID: 30226143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological serosurvey of chikungunya fever post outbreak at Tanjung Sepat, Malaysia.
    Khor CS; Teoh BT; Sam SS; Khoo HY; Azizan NS; CheMatSeri A; Chin KL; Hamim ZR; Mohamed-Romai-Noor NA; Yaacob CN; Abd-Jamil J; Lee HY; Soh YH; AbuBakar S
    J Infect Dev Ctries; 2023 Jan; 17(1):118-124. PubMed ID: 36795935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiological survey on chikungunya in endemic zones for arboviruses in Brazil, 2019.
    Braga DAO; Barreto FKA; Paiva CN; Ramalho ILC; Cavalcanti LPG; Alencar CH
    Zoonoses Public Health; 2021 Dec; 68(8):955-964. PubMed ID: 34472209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006.
    Sissoko D; Ezzedine K; Moendandzé A; Giry C; Renault P; Malvy D
    Trop Med Int Health; 2010 May; 15(5):600-7. PubMed ID: 20214759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decadal Change in Seroprevalence of Chikungunya Virus Infection in Pune City, India.
    Tomar SJ; Alagarasu K; More A; Nadkarni M; Bachal R; Bote M; Patil J; Venkatesh V; Parashar D; Tandale BV
    Viruses; 2022 May; 14(5):. PubMed ID: 35632740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of Chikungunya fever in Mayotte, Comoros archipelago, 2005-2006.
    Sissoko D; Malvy D; Giry C; Delmas G; Paquet C; Gabrie P; Pettinelli F; Sanquer MA; Pierre V
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):780-6. PubMed ID: 18400240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikungunya antibodies detected in non-human primates and rats in three Indian Ocean islands after the 2006 ChikV outbreak.
    Vourc'h G; Halos L; Desvars A; Boué F; Pascal M; Lecollinet S; Zientara S; Duval T; Nzonza A; Brémont M
    Vet Res; 2014 May; 45(1):52. PubMed ID: 24885529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
    Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey.
    Kumar MS; Kamaraj P; Khan SA; Allam RR; Barde PV; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Kumar CPG; Sabarinathan R; Kumar VS; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Dinesh ER; Karunakaran T; Govindhasamy C; Rajasekar TD; Jeyakumar A; Suresh A; Augustine D; Kumar PA; Kumar R; Dutta S; Toteja GS; Gupta N; Clapham HE; Mehendale SM; Murhekar MV
    Lancet Microbe; 2021 Jan; 2(1):e41-e47. PubMed ID: 35544228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006.
    Sissoko D; Ezzedine K; Giry C; Moendandzé A; Lernout T; D'Ortenzio E; Pettinelli F; Malvy D
    PLoS One; 2010 Nov; 5(11):e14141. PubMed ID: 21152441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent seroprevalence of dengue and chikungunya: inference from a cross-sectional analysis in Esmeraldas Province in coastal Ecuador.
    Chis Ster I; Rodriguez A; Romero NC; Lopez A; Chico M; Montgomery J; Cooper P
    BMJ Open; 2020 Oct; 10(10):e040735. PubMed ID: 33067302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.
    Kang H; Auzenbergs M; Clapham H; Maure C; Kim JH; Salje H; Taylor CG; Lim A; Clark A; Edmunds WJ; Sahastrabuddhe S; Brady OJ; Abbas K
    Lancet Infect Dis; 2024 May; 24(5):488-503. PubMed ID: 38342105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of chikungunya virus infection among HIV-infected adults in French Caribbean Islands of Martinique and Guadeloupe in 2015: A cross-sectional study.
    Curlier E; Fagour L; Herrmann-Storck C; Staelen A; Vingadassalom I; Breurec S; Abel S; Pierre-François S; Jean-Marie J; Laouénan C; Césaire R; Hoen B; Cabié A
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009267. PubMed ID: 33836004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of dengue virus serotype 3 on Mayotte Island, Indian Ocean.
    Lernout T; Giry C; Binder P; Zumbo B; Durquety E; Lajoinie G; D'Ortenzio E; Filleul L
    East Afr J Public Health; 2011 Jun; 8(2):155-6. PubMed ID: 22066303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of chikungunya seropositivity in healthy Malaysian adults residing in outbreak-free locations: chikungunya seroprevalence results from the Malaysian Cohort.
    Azami NA; Salleh SA; Shah SA; Neoh HM; Othman Z; Zakaria SZ; Jamal R
    BMC Infect Dis; 2013 Feb; 13():67. PubMed ID: 23379541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.